<DOC>
	<DOC>NCT00289406</DOC>
	<brief_summary>The goal of this study is to compare the antihypertensive effect and tolerability of S-amlodipine gentisate with those of amlodipine besylate in patients with mild to moderate hypertension.</brief_summary>
	<brief_title>Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>patients are required to have a mean cuff sitting diastolic blood pressure of ≥90 and ≤109 mmHg after successful completion of the 2week placebo runin period any serious disorder that could limit the ability of the patient to participate in the study significant cardiovascular disease (angina, myocardial infarction, cerebrovascular disease, or significant arrhythmia in the preceding 6 months) uncontrolled diabetes mellitus (serum glucose level ≥140 mg/dl) insulin dependent diabetes mellitus (type I) secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>hypertension</keyword>
</DOC>